Catalyst Pharmaceuticals (CPRX) News Today $21.45 +0.26 (+1.23%) Closing price 04:00 PM EasternExtended Trading$21.49 +0.04 (+0.19%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CPRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Catalyst Pharmaceuticals, Inc. (CPRX) Cash Flow - Yahoo Finance4 hours ago | finance.yahoo.comCatalyst Pharmaceuticals is Now Oversold (CPRX) - Nasdaq4 hours ago | nasdaq.comAre Investors Undervaluing Catalyst Pharmaceuticals (CPRX) Right Now? - NasdaqJuly 2 at 11:11 AM | nasdaq.comMoran Wealth Management LLC Purchases 21,135 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)June 27, 2025 | marketbeat.comCPRX - Catalyst Pharmaceuticals Inc Financials - MorningstarJune 25, 2025 | morningstar.comMCPRX Catalyst Pharmaceuticals, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Consensus Rating of "Buy" by BrokeragesJune 25, 2025 | marketbeat.comXML Financial LLC Sells 20,000 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)June 25, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Holdings Raised by Nilsine Partners LLCJune 22, 2025 | marketbeat.comCatalyst Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:CPRX)June 22, 2025 | americanbankingnews.comCatalyst Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:CPRX)June 20, 2025 | marketbeat.comCatalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings GrowthJune 18, 2025 | finance.yahoo.comBfsg LLC Has $3.93 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)June 17, 2025 | marketbeat.comAssenagon Asset Management S.A. Acquires Shares of 96,629 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)June 17, 2025 | marketbeat.comGAMMA Investing LLC Has $1.64 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)June 15, 2025 | marketbeat.comPreethi Sundaram Implements A Sell Strategy: Offloads $103K In Catalyst Pharmaceuticals StockJune 14, 2025 | benzinga.comPreethi Sundaram Sells 1,600 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) StockJune 13, 2025 | insidertrades.comStanley Laman Group Ltd. Invests $3.50 Million in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)June 13, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Insider Preethi Sundaram Sells 1,600 SharesJune 12, 2025 | marketbeat.comInsider Selling: Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Insider Sells 2,324 Shares of StockJune 12, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Shares Down 5.2% - Here's What HappenedJune 12, 2025 | marketbeat.comDirector Of Catalyst Pharmaceuticals Sold $5.22M In StockJune 11, 2025 | benzinga.comMetsera Shows Rising Price Performance With Jump To 92 RS RatingJune 11, 2025 | msn.com19,000 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Acquired by Wesbanco Bank Inc.June 11, 2025 | marketbeat.comARS Pharmaceuticals Earns Relative Strength Rating UpgradeJune 9, 2025 | msn.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Reaches New 12-Month High - What's Next?June 9, 2025 | marketbeat.com117,374 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Bought by Bridge City Capital LLCJune 9, 2025 | marketbeat.comCantor Fitzgerald Upgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to Strong-BuyJune 6, 2025 | marketbeat.comRichard P Slaughter Associates Inc Sells 37,912 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)June 4, 2025 | marketbeat.comCatalyst Pharmaceuticals (NasdaqCM:CPRX) Appoints Dr. William Andrews As New Chief Medical OfficerJune 4, 2025 | finance.yahoo.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Holdings Increased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 3, 2025 | marketbeat.comCatalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical OfficerJune 2, 2025 | globenewswire.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $3.73 Million in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)June 2, 2025 | marketbeat.comMackenzie Financial Corp Grows Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)June 2, 2025 | marketbeat.comWhat is Zacks Research's Forecast for CPRX FY2025 Earnings?June 2, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Consensus Recommendation of "Buy" from BrokeragesJune 1, 2025 | marketbeat.comCatalyst: Solid Business Model Propels Growth For This Buy And Build PharmaMay 31, 2025 | seekingalpha.comZacks Research Issues Positive Estimate for CPRX EarningsMay 31, 2025 | marketbeat.comSquarepoint Ops LLC Increases Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)May 30, 2025 | marketbeat.com14,669 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Acquired by Armis Advisers LLCMay 28, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Buys Shares of 18,173 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)May 28, 2025 | marketbeat.comVoloridge Investment Management LLC Decreases Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)May 27, 2025 | marketbeat.comProShare Advisors LLC Grows Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)May 27, 2025 | marketbeat.com85,059 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Acquired by Castlekeep Investment Advisors LLCMay 26, 2025 | marketbeat.comNeo Ivy Capital Management Purchases New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)May 26, 2025 | marketbeat.comWoodline Partners LP Sells 53,489 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)May 26, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Millennium Management LLCMay 26, 2025 | marketbeat.comCetera Investment Advisers Grows Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)May 26, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Position Decreased by Jane Street Group LLCMay 26, 2025 | marketbeat.comNuveen Asset Management LLC Boosts Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)May 25, 2025 | marketbeat.com Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CPRX Media Mentions By Week CPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPRX News Sentiment▼1.010.90▲Average Medical News Sentiment CPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPRX Articles This Week▼57▲CPRX Articles Average Week Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ASND News VTRS News BPMC News BBIO News VRNA News ROIV News ELAN News RVMD News LEGN News GRFS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CPRX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPRX Stock Alerts